We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stellar Acquires Exclusive, Worldwide License to C. diff Immunotherapy Technology

News   Jul 31, 2013

 
Stellar Acquires Exclusive, Worldwide License to C. diff Immunotherapy Technology
 
 
 

RELATED ARTICLES

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

Needle-shaped Sensors Can Detect Multiple Sepsis Indicators

News

Using a microelectrode, a biosensor device is used to detect if one of the protein biomarkers of sepsis– interleukin-6 – is present in the bloodstream. IL-6 is a molecule secreted by the immune system and the levels of it in the blood increase in many of those who have the condition.

READ MORE

TB's Suicide System Could Be Its Undoing

News

TB holds a special toxin-antitoxin system with spectacular action: once the toxin is activated, all bacterial cells die, stopping the disease. Researchers are investigating how to turn the bacteria on itself.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE